Affinity Investment Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 242.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 64,635 shares of the healthcare conglomerate’s stock after buying an additional 45,754 shares during the period. UnitedHealth Group makes up approximately 1.4% of Affinity Investment Advisors LLC’s portfolio, making the stock its 24th largest position. Affinity Investment Advisors LLC’s holdings in UnitedHealth Group were worth $11,985,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the stock. Patriot Financial Group Insurance Agency LLC increased its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares in the last quarter. Cribstone Capital Management LLC increased its stake in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares in the last quarter. Kings Point Capital Management increased its stake in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares in the last quarter. Founders Capital Management purchased a new stake in shares of UnitedHealth Group during the first quarter valued at $135,000. Finally, Parkside Financial Bank & Trust increased its stake in shares of UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. 86.21% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Incorporated (NYSE UNH) traded down 0.57% on Wednesday, reaching $195.61. 558,790 shares of the company’s stock were exchanged. The firm has a 50 day moving average of $191.39 and a 200-day moving average of $177.02. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.88. The stock has a market cap of $189.13 billion, a price-to-earnings ratio of 23.50 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion for the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the previous year, the business earned $1.96 EPS. UnitedHealth Group’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts forecast that UnitedHealth Group Incorporated will post $9.86 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 35.13%.

COPYRIGHT VIOLATION WARNING: This article was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/08/30/unitedhealth-group-incorporated-unh-position-increased-by-affinity-investment-advisors-llc.html.

Several equities research analysts have recently weighed in on the stock. Cowen and Company reissued an “outperform” rating and issued a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 target price on shares of UnitedHealth Group in a research note on Friday, August 18th. UBS AG reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Finally, Leerink Swann reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $203.41.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now directly owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold a total of 30,540 shares of company stock worth $5,748,970 over the last 90 days. 0.89% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.